Nitrosatable drug exposure during the first trimester of pregnancy and selected congenital malformations
Birth Defects Research Part A: Clinical and Molecular Teratology · 2012-09 · 94 (9) · 701-713
DOI: 10.1002/bdra.23060 ↗Kurz gefasst
Fachartikel in der Zeitschrift Birth Defects Research Part A: Clinical and Molecular Teratology, online erschienen am 18.08.2012. Verfasst von Jean D Brender und 13 weiteren Autor:innen. Beteiligte Einrichtung: Texas A&M Health Science Center, School of Rural Public Health, College Station, Texas 77843-1266, USA. jdbrender@srph.tamhsc.edu. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIEHS NIH HHS, PHS HHS.
Abstract (Originalsprache)
BACKGROUND Nitrosatable drugs can react with nitrite in the stomach to form N ‐nitroso compounds, and results from animal studies suggest that N ‐nitroso compounds are teratogens. With data from the National Birth Defects Prevention Study, the relation between prenatal exposure to nitrosatable drugs and limb deficiencies, oral cleft, and heart malformations in offspring was examined. METHODS Maternal reports of drugs taken during the first trimester of pregnancy were classified with respect to nitrosatability for mothers of 741 babies with limb deficiencies, 2774 with oral cleft malformations, 8091 with congenital heart malformations, and 6807 without major congenital malformations. Nitrite intake was estimated from maternal responses to a food frequency questionnaire. RESULTS Isolated transverse limb deficiencies and atrioventricular septal defects were associated with secondary amine drug exposures (adjusted odds ratios [aORs], 1.51; 95% confidence limit [CI], 1.11–2.06 and aOR, 1.97; 95% CI, 1.19–3.26, respectively). Tertiary amines were associated with hypoplastic left heart syndrome (aOR, 1.50; 95% CI, 1.10–2.04) and single ventricle (aOR, 1.61; 95% CI, 1.06–2.45). These two malformations were also significantly associated with amide drugs. For several malformations, the strongest associations with nitrosatable drug use occurred among mothers with the highest estimated dietary nitrite intake, especially for secondary amines and atrioventricular septal defects (highest tertile of nitrite, aOR, 3.30; 95% CI, 1.44–7.58). CONCLUSION Prenatal exposure to nitrosatable drugs may be associated with several congenital malformations, especially with higher nitrite intake. The possible interaction between nitrosatable drugs and dietary nitrite on risk of congenital malformations warrants further attention. Birth Defects Research (Part A) 94:701–713, 2012. © 2012 Wiley Periodicals, Inc.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Texas A&M Health Science Center, School of Rural Public Health, College Station, Texas 77843-1266, USA. jdbrender@srph.tamhsc.edu
Förderung
- NIEHS NIH HHS
- PHS HHS
Zitieren
APA
Brender, J. D., Werler, M. M., Shinde, M. U., Vuong, A. M., Kelley, K. E., Huber, J. C., Sharkey, J. R., Griesenbeck, J. S., Romitti, P. A., Malik, S., Suarez, L., Langlois, P. H., Canfield, M. A., & National Birth Defects Prevention Study (2012). Nitrosatable drug exposure during the first trimester of pregnancy and selected congenital malformations. Birth Defects Research Part A: Clinical and Molecular Teratology, 94(9), 701-713. https://doi.org/10.1002/bdra.23060
Vancouver
Brender JD, Werler MM, Shinde MU, Vuong AM, Kelley KE, Huber JC, et al. Nitrosatable drug exposure during the first trimester of pregnancy and selected congenital malformations. Birth Defects Research Part A: Clinical and Molecular Teratology. 2012;94(9):701-713. doi:10.1002/bdra.23060
BibTeX
@article{Brender2012,
author = {Brender, Jean D and Werler, Martha M and Shinde, Mayura U and Vuong, Ann M and Kelley, Katherine E and Huber, John C and Sharkey, Joseph R and Griesenbeck, John S and Romitti, Paul A and Malik, Sadia and Suarez, Lucina and Langlois, Peter H and Canfield, Mark A and National Birth Defects Prevention Study, National Birth Defects Prevention Study},
title = {Nitrosatable drug exposure during the first trimester of pregnancy and selected congenital malformations},
journal = {Birth Defects Research Part A: Clinical and Molecular Teratology},
year = {2012},
volume = {94},
number = {9},
pages = {701--713},
doi = {10.1002/bdra.23060}
}
EUVIMED